Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZG7E
|
|||
Drug Name |
PMID28460551-Compound-3
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Whitehead Institute for Biomedical Research
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H23N5O2S
|
|||
Canonical SMILES |
CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N
|
|||
InChI |
1S/C25H23N5O2S/c1-29-13-17(15-7-2-4-9-19(15)29)21-22(24(32)28-23(21)31)18-14-30(11-6-12-33-25(26)27)20-10-5-3-8-16(18)20/h2-5,7-10,13-14H,6,11-12H2,1H3,(H3,26,27)(H,28,31,32)
|
|||
InChIKey |
DSXXEELGXBCYNQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 125314-64-9
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:38912
|
References | Top | |||
---|---|---|---|---|
REF 1 | Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jul;27(7):753-761. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.